44
Madrid
Updated:
Save
The treatment of cancers with metastases and in advanced stages resistant to treatment continues to be a great challenge for medicine. Patients with cancers that have spread throughout their body have Fewer treatment options because they may show drug resistance and that causes the disease to progress, reducing your life expectancy and quality of life. However, things may be starting to change.
“The key is in the conjugated antibodies“, highlights Joaquin Gavilaof the Valencian Institute of Oncology (IVO).
“They contain an antibody that is directed at a structure or a receptor on the cells on the cell surface, in this case HER2, and a chemotherapy drug,” he explains. Sparrowhawk.